Back

Timing of angiotensin receptor-neprilysin inhibitor initiation in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry

25 August 2023 (17:15 - 17:50)
Organised by: Logo
Congress Presentation Part of: Pharmacological therapy in heart failure (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail
Initiation, titration, and discontinuation - utilization of heart failure medicines in England (EVOLUTION HF UK)
Doctor R. Zhang (London, GB)
Abstract Slides Video
Presentation thumbnail
Statin and risk of dementia in patients with heart failure
Mrs Q. Ren (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Soluble guanylate cyclase in heart failure: A network meta-analysis and subgroup analyses of reduced and preserved ejection fraction.
Doctor M. Ibrahim (Flint, US)
Abstract Slides Video
Presentation thumbnail
Feasibility, efficacy and safety of early and rapid initiation of evidence-based treatment for patients with HFrEF- a real world experience of the "four drugs in four weeks" strategy
Doctor S. Sze (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Impact of pharmacological treatment for heart failure after myocardial recovery in arrhythmia-induced cardiomyopathy.
Mr L. Dominguez Rodriguez (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacological therapy in heart failure (2)

The Event

Event poster

ESC Congress 2023

25 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
6 years of ARNI use in Israel - effectiveness analysis in real world data
thumbnail
Congress Presentation
Real-world comparison between ARNI and RAS Blockade in Patients with HFrEF
thumbnail
Congress Session
Pharmacotherapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources